Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 54 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: Eszopiclone Clear all

Conditions: Inappropriate Prescribing
Interventions: Z-drug Default Quantity, Redirection + Accountable Justification; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 444 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Relapsing Remitting Multiple Sclerosis, Sleep Initiation and Maintenance Disorders, Fatigue
Interventions: eszopiclone, placebo; Drug · Other
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Schizophrenia
Interventions: eszopiclone, placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 45 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Depression, Anxiety, Insomnia
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Posttraumatic Stress Disorders
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obstructive Sleep Apnea
Interventions: Rozerem (Ramelteon), Lunesta (Eszopiclone), Historical Controls; Drug · Other
Lead sponsor: Southern California Institute for Research and Education; Other
Eligibility: 18 Years to 65 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Sleep Apnea, Obstructive
Interventions: Placebo pill, Sedative, Room air, Oxygen; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 79 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Major Depressive Disorder, Insomnia
Interventions: escitalopram and eszopiclone, Escitalopram, eszopiclone, and placebo, Escitalopram; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 64 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Insomnia
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 388 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 82
States / cities: Birmingham, Alabama • Chandler, Arizona • Glendale, Arizona + 69 more

Conditions: Primary Insomnia
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 21 Years to 64 Years
Enrollment: 830 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 58
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 55 more

Conditions: Schizophrenia
Interventions: eszopiclone, placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 45 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Primary Insomnia
Interventions: eszopiclone, placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 25 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Fibromyalgia, Insomnia
Interventions: Eszopiclone, placebo; Drug
Lead sponsor: Lesley A. Allen, Ph.D.; Other
Eligibility: 18 Years to 64 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Obstructive Sleep Apnea
Interventions: Eszopiclone, Placebo control; Drug
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years to 64 Years
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Sleep Initiation and Maintenance Disorders
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 20 Years to 75 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Post-Traumatic Stress Disorders
Interventions: Eszopiclone; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 64 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Parkinson's Disease, Insomnia
Interventions: eszopiclone, placebo; Drug · Other
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 35 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 4
States / cities: Suwanee, Georgia • Edison, New Jersey • Piscataway, New Jersey + 1 more

Conditions: Insomnia, Generalized Anxiety Disorder
Interventions: Eszopiclone (Lunesta); Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 64
States / cities: Birmingham, Alabama • Mesa, Arizona • Scottsdale, Arizona + 61 more

Conditions: Osteoarthritis, Insomnia
Interventions: Placebo, Eszopiclone; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Sleep, Insomnia, Insulin Resistance
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 35 Years to 64 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Insomnia
Interventions: Eszopiclone, Placebo, Escitalopram; Drug
Lead sponsor: Lehigh Center for Clinical Research; Other
Eligibility: 65 Years to 85 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Allentown, Pennsylvania

Conditions: Insomnia
Interventions: eszopiclone; Drug
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Insomnia, Schizophrenia, Schizoaffective Disorder, Sleep Disorders
Interventions: Eszopiclone, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Primary Insomnia, Sleep Initiation and Maintenance Disorders
Interventions: eszopiclone 3 mg qHS, General cognitive/behavioral interventions for insomnia; Drug · Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania